Renal involvement in Fabry disease from Tunisian families: Six case reports.

Syrine Tlili, Hiba Ghabi, Ikram Mami, Fethi Ben Hmida, Lamia Rais, Mohamed Karim Zouaghi
{"title":"Renal involvement in Fabry disease from Tunisian families: Six case reports.","authors":"Syrine Tlili, Hiba Ghabi, Ikram Mami, Fethi Ben Hmida, Lamia Rais, Mohamed Karim Zouaghi","doi":"10.5527/wjn.v15.i2.109420","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Fabry disease (FD) is a rare X-linked metabolic disorder caused by a deficiency or absence of alpha-galactosidase A activity. It leads to the progressive accumulation of glycosphingolipids in various organs, resulting in multisystem dysfunction. Renal involvement has been reported in 50% of affected males and 20% of females, with a wide phenotypic spectrum-even within the same family.</p><p><strong>Case summary: </strong>We identified six cases of FD with renal involvement from our institutional database, originating from three unrelated families (A, B, and C). Five patients were male, aged 16 to 29 years (mean: 21.3; median: 22.5), and one was a 16-year-old female. All patients presented with proteinuria, including one with nephrotic syndrome. Hypertension was documented in two cases. Renal function varied from hyperfiltration in four patients to advanced chronic kidney disease in two, one of whom progressed to end-stage renal disease requiring hemodialysis. Renal biopsy, performed in two cases, revealed characteristic vacuolated podocytes consistent with Fabry nephropathy. Four patients received enzyme replacement therapy.</p><p><strong>Conclusion: </strong>Renal involvement in FD is often underdiagnosed due to the heterogeneity of clinical presentation. Early diagnosis and timely initiation of enzyme replacement therapy can delay progression to chronic kidney disease and improve long-term outcomes.</p>","PeriodicalId":94272,"journal":{"name":"World journal of nephrology","volume":"15 2","pages":"109420"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13324585/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5527/wjn.v15.i2.109420","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Fabry disease (FD) is a rare X-linked metabolic disorder caused by a deficiency or absence of alpha-galactosidase A activity. It leads to the progressive accumulation of glycosphingolipids in various organs, resulting in multisystem dysfunction. Renal involvement has been reported in 50% of affected males and 20% of females, with a wide phenotypic spectrum-even within the same family.

Case summary: We identified six cases of FD with renal involvement from our institutional database, originating from three unrelated families (A, B, and C). Five patients were male, aged 16 to 29 years (mean: 21.3; median: 22.5), and one was a 16-year-old female. All patients presented with proteinuria, including one with nephrotic syndrome. Hypertension was documented in two cases. Renal function varied from hyperfiltration in four patients to advanced chronic kidney disease in two, one of whom progressed to end-stage renal disease requiring hemodialysis. Renal biopsy, performed in two cases, revealed characteristic vacuolated podocytes consistent with Fabry nephropathy. Four patients received enzyme replacement therapy.

Conclusion: Renal involvement in FD is often underdiagnosed due to the heterogeneity of clinical presentation. Early diagnosis and timely initiation of enzyme replacement therapy can delay progression to chronic kidney disease and improve long-term outcomes.

突尼斯家庭法布里病累及肾脏6例报告
背景:法布里病(FD)是一种罕见的x连锁代谢疾病,由α -半乳糖苷酶a活性缺乏引起。它导致鞘糖脂在各器官的逐渐积累,导致多系统功能障碍。据报道,50%的男性和20%的女性有肾脏受累,其表型谱很广,甚至在同一家族中也是如此。病例总结:我们从我们的机构数据库中确定了6例FD合并肾脏累及,来自三个不相关的家族(A, B和C)。5例患者为男性,年龄16- 29岁(平均21.3岁,中位数22.5岁),1例为16岁女性。所有患者均表现为蛋白尿,包括1例肾病综合征。高血压2例。肾功能各不相同,从4例患者的高滤过到2例晚期慢性肾脏疾病,其中1例进展为终末期肾脏疾病,需要血液透析。两例肾活检显示足细胞空泡化,符合法布里肾病的特征。4名患者接受了酶替代治疗。结论:由于临床表现的异质性,FD累及肾脏常被漏诊。早期诊断和及时开始酶替代治疗可以延缓慢性肾脏疾病的进展并改善长期预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书